Plant Health Care has released a trading update for its half year ended June 2021 which affirms that trading for the full year is expected to be in line with expectations. Total revenues increased 13% to $3.5m, which is 6% ahead of the $3.3m in our model. Gross margins decreased to 56% (H1/20: 59%) due to currency effects, but this is in line with the decrease to 56.1% we had modelled for the period. Costs increased 18% to $4.7 which is in line with expectations. Cash used in operations reduced ....
